Attached files
| file | filename |
|---|---|
| EX-99.1 - CORINDUS VASCULAR ROBOTICS, INC. PRESENTATION DATED NOVEMBER 2014 - Corindus Vascular Robotics, Inc. | ex99-1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): November 19, 2014
| CORINDUS VASCULAR ROBOTICS, INC. |
(Exact Name of Registrant as Specified in its Charter)
| Nevada | 333-176581 | 30-0687898 | ||
|
(State or Other Jurisdiction of Incorporation) |
(Commission File Number) | (IRS Employer Identification No.) |
|
309 Waverley Oaks Rd., Suite 105 Waltham, MA 02452 |
|
(Address of Principal Executive Office) (Zip Code)
|
Registrant's telephone number, including area code: (508) 653-3335
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):
| £ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
| £ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
| £ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
| £ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 7.01. Regulation FD Disclosure.
Corindus Vascular Robotics, Inc. is furnishing as Exhibit 99.1 to this Current Report on Form 8-K a presentation which will be used, in whole or in part, and subject to modification, at a conference on November 19, 2014, and at subsequent conferences.
The information in this Current Report on Form 8-K (including the exhibit) is being furnished pursuant to Item 7.01 of Form 8-K and shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor will any of such information or exhibits be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, except as expressly set forth by specific reference in such filing.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
| Exhibit Number |
Description |
| 99.1 | Corindus Vascular Robotics, Inc. presentation dated November 2014. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Date: November 19, 2014 | CORINDUS VASCULAR ROBOTICS, INC. | |
| By: | s/ David M. Handler | |
| Name: | David M. Handler | |
| Title: | Chief Executive Officer | |
EXHIBIT INDEX
| Exhibit Number |
Description |
| 99.1 | Corindus Vascular Robotics, Inc. presentation dated November 2014. |